Bluebook
Pharma Services March 2023
2023 - March: Report on M&A and financing activity in the pharma services drug development industry for CEOs and private equity professionals
Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
Highlights from this edition:
- CROMSOURCE was acquired by ClinChoice
- Trans Genic Inc. (TSE:2342) announced its acquisition of MASC Co., Ltd.
- Byteflies NV has closed a $4.8MM Series A Financing, led by Sensinnovat bvba